PTC Therapeutics, Inc. (PTCT) NASDAQ

65.37

+2.35(+3.73%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap3.47B
Enterprise Value5.16B
P/E Ratio8.12
PEG Ratio1.33
Price/Sales Ratio2.94
Price/Book Ratio-24.73
Enterprise/Revenue2.59
Enterprise/EBITDA5.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.36
Operating Margin0.41

Management Effectiveness

Return On Assets0.24
Return On Equity-0.99

Income Statement

Revenue806.78M
Revenue/Share22.58
Gross Profit749.38M
EBITDA-120.46M
Net Income-363.3M
Diluted EPS-4.73

Balance Sheet

Total Cash1.99B
Total Cash/Share25.45
Total Debt388.17M
Total Debt/Equity-1.88
Current Ratio3.62
Book Value Per Share-2.64

Price History

52-Week Change84.82
52-Week High67.4
52-Week Low34.57
Moving Average 50 Days53.73
Moving Average 200 Days49.74

Statistics

Average Volume1.26M
Shares Outstanding79.44M
% Held by Institutions94.55

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A